Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-05409-z ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Katarzyna Paal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Therapeutic Radiology and Oncology, Comprehensive Cancer Center, Medical University of Graz, 8036, Graz, Austria. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Inflammation, Fibrinogen, C-Reactive Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Graz.
Abstract (Originalsprache)
Purpose
The present study was performed to investigate the association of prostate cancer radiotherapy with inflammaging, a condition characterized by the elevation of inflammatory blood parameters that significantly increases the susceptibility to the occurrence or progression of age-related conditions. Patients and Methods A total of 306 patients treated with curative radiotherapy (RT) for prostate cancer were enrolled into the prospective study. Aging-related inflammatory parameters including C-reactive protein (CRP), albumin, fibrinogen, cholesterol, platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) were analyzed before and at the end of RT, and 3 and 15 months after completion of the RT. Statistical analysis was performed using non-parametric variance analysis.
Results
Overall variance analysis showed a significant influence of RT on all inflammatory parameters (p < 0.001) with the exception of CRP (p = 0.498). Pairwise analysis revealed a significant elevation of fibrinogen (p = 0.041), NLR (p < 0.001), and PLR levels (p < 0.001) as well as a significant decrease of albumin (p < 0.001) and cholesterol levels (p < 0.001) during the RT course. After completion of RT, a significant recovery was detected for NLR, PLR, albumin and cholesterol. However, 15 months after RT, PLR, fibrinogen, and cholesterol remained significantly lower when compared to the baseline (p < 0.001).
Conclusion
Our results indicate that radiation therapy triggers chronic inflammatory processes that could contribute to the development, acceleration or worsening of age-related alterations and conditions. Further investigations to estimate the long-term consequences of curative radiation therapy on clinical manifestations of aging are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Therapeutic Radiology and Oncology, Comprehensive Cancer Center, Medical University of Graz, 8036, Graz, Austria.
- Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036, Graz, Austria.
- Department of Therapeutic Radiology and Oncology, Comprehensive Cancer Center, Medical University of Graz, 8036, Graz, Austria. tanja.langsenlehner@medunigraz.at.
Förderung
- Medical University of Graz
Zitieren
APA
Paal, K., Stranz, B., Thurner, E. M., Niedrist, T., Renner, W., & Langsenlehner, T. (2024). Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation. World Journal of Urology. https://doi.org/10.1007/s00345-024-05409-z
Vancouver
Paal K, Stranz B, Thurner EM, Niedrist T, Renner W, Langsenlehner T. Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation. World Journal of Urology. 2024. doi:10.1007/s00345-024-05409-z
BibTeX
@article{Paal2024,
author = {Paal, Katarzyna and Stranz, Bettina and Thurner, Eva-Maria and Niedrist, Tobias and Renner, Wilfried and Langsenlehner, Tanja},
title = {Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-05409-z}
}
EUVIMED